Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
Read original at benzingaStocks · News reference
Leerink Partners Maintains Market Perform on 10x Genomics, Raises Price Target to $40
Leerink Partners analyst Mike Kratky maintains 10x Genomics (NASDAQ:TXG) with a Market Perform and raises the price target from $23 to $40.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 17, 2026, 6:10 PM
- Checked
- Jul 17, 2026, 6:10 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Stephens & Co. Maintains Overweight on 10x Genomics, Raises Price Target to $65
Stephens & Co. analyst Mason Carrico maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $50 to $65.
Read original at benzingaPiper Sandler Maintains Neutral on 10x Genomics, Raises Price Target to $47
Piper Sandler analyst David Westenberg maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $42 to $47.
Read original at benzinga10x Genomics shares are trading higher after Canaccord raised its price target on the stock from $50 to $60.
Read original at benzinga